BH-501352

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NameBH-501352
Drug Alias NameBH-501352BH501352
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlossomHill Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlossomHill Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A